Fingolimod Completed Phase 4 Trials for Disseminated Sclerosis / Relapsing-Remitting Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care4
clinicaltrials.gov IdentifierTitleDrugs
NCT01578330A 12 -Month, Open-label, Multi-center Study to Explore the Health Outcomes of FTY720